semaglutide masld 📘 AASLD adds to practice guidance: Key updates The AASLD has updated its MASLD practice guidance to formally include semaglutide as a treatment option for adults with MASH and F2–F3 Is Semaglutide the treatment for

In fact, the new tool was rolled out early, on June 2

Key takeaways Nearly 3 in 4 UK GLP-1 users have felt more confident since starting the medication

A nutrient-dense plan designed to support GLP-1 medications by focusing on protein, healthy fats, fiber, and whole foods, promoting better health outcomes and reducing side effects

Supply Chain and Go-to-Market Trends The market is seeing increased investment in scalable nutrition infrastructure, including: Expansion of co-manufacturing and RTD production capabilities Partnerships with protein and functional ingredient suppliers Growth of pharmacy-adjacent and wellness retail distribution Increased investment in cold-chain and convenience logistics Strengthening direct-to-consumer and e-commerce fulfillment systems These strategies are helping suppliers accelerate commercialization while maintaining product quality and formulation consistency

Pricing Information The new weight loss medication Wegovy should be available at retail pharmacies on or around June 17th, 2021